Concepedia

Virginia Snell

VS

Statistics

Publications

17

Citations

1.4K

H-Index

15

Active since

1996

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Research & Development Corporation

Virginia Snell is an author at The University of Texas MD Anderson Cancer Center specializing in life sciences, apoptosis, and cell biology.

Publications per year

1996–2003

17

Publications

17

MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival

Bei Zheng, Paolo Fiumara, Yang V. Li et al. · Blood · 2003 · 211 citations · Full text

, , +13

The anti‐apoptotic genes Bcl‐X<sub>L</sub> and Bcl‐2 are over‐expressed and contribute to chemoresistance of non‐proliferating leukaemic CD34<sup>+</sup> cells

Marina Konopleva, Shourong Zhao, Wei Hu et al. · British Journal of Haematology · 2002 · 170 citations

, , +17

Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax

M Lisovsky, Zeev Estrov, X. Zhang et al. · Blood · 1996 · 144 citations · Full text

, , +16

Functional expression of receptor activator of nuclear factor κB in Hodgkin disease cell lines

Paolo Fiumara, Virginia Snell, Yang Li et al. · Blood · 2001 · 129 citations · Full text

, , +10

Activity of TNF‐related apoptosis‐inducing ligand (TRAIL) in haematological malignancies

Virginia Snell, Katharina Clodi, Shourong Zhao et al. · British Journal of Haematology · 1997 · 122 citations

, , +17

1–5 of 17